Characteristics of respiratory virus infections in autologous hematopoietic stem cell transplantation patients, a prospective study, Bern, Switzerland, 2015-2017.

Moret, Fabienne; Marschall, Jonas; Atkinson, Andrew; Farag, Sarah; Zimmerli, Stefan; Pabst, Thomas; Sommerstein, Rami (2021). Characteristics of respiratory virus infections in autologous hematopoietic stem cell transplantation patients, a prospective study, Bern, Switzerland, 2015-2017. Infectious diseases, 53(4), pp. 274-280. Taylor & Francis 10.1080/23744235.2021.1871642

[img] Text
R._Sommerstein.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (1MB)

BACKGROUND

The epidemiology of respiratory virus infections (RVI) in patients undergoing autologous haematopoietic stem cell transplantation (auto-SCT) is not well described.

METHODS

Our goal was to describe the epidemiology of respiratory virus infections (RVI) in patients undergoing autologous haematopoietic stem cell transplantation (auto-SCT) in a single tertiary centre observation study during two respiratory virus seasons (2015-2017). All symptomatic auto-SCT patients were tested for RVI by nasopharyngeal swab.

RESULTS

156 transplantation episodes were included, 69% were male and, the median age was 57 years. We detected 19 RVIs in 156 transplantation episodes (12%). The median time to RVI after hospitalization was 13 days [IQR 7-13] and 15/19 (79%) had a possible nosocomial origin (occurrence ≥ 5 days after admission). The nosocomial infections included 5/15 (33%) 'severe' RVIs (3 influenza viruses, 1 parainfluenza virus, and 1 adenovirus) as well as 10/15 (66%) non-severe virus infections (including human rhinovirus and human coronavirus).

CONCLUSION

In approximately 10% of auto-SCT transplantation episodes, an RVI with likely nosocomial origin was detected and included 'severe viruses' such as influenza. Our study suggests that infection prevention measures in auto-SCT patients can be improved.

ABBREVIATIONS

AdV: adenovirus; ALL: acute lymphatic leukaemia; AML: acute myeloid leukaemia; auto-SCT: autologous haematopoietic stem cell transplantation; hCoV: human coronavirus; HD: Hodgkin's disease; hMPV: human metapneumovirus; HRV: human rhinovirus; HSCT: allogeneic haematopoietic stem cell transplantation; IQR: interquartile range; GCT: germ cell tumour; MM: multiple myeloma; NHL: non-Hodgkin lymphoma; PIV: parainfluenza virus; RSV: respiratory syncytial virus.

Item Type:

 Journal Article (Original Article)

Division/Institute:

 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

 Marschall, Jonas, Atkinson, Andrew David, Farag, Sarah Ahmed Ibrahim, Zimmerli, Stephan, Pabst, Thomas Niklaus, Sommerstein, Rami

Subjects:

 600 Technology > 610 Medicine & health

ISSN:

 2374-4243

Publisher:

 Taylor & Francis

Language:

 English

Submitter:

 Annelies Luginbühl

Date Deposited:

 15 Feb 2021 16:36

Last Modified:

 02 Mar 2023 23:34

Publisher DOI:

 10.1080/23744235.2021.1871642

PubMed ID:

 33475447

Uncontrolled Keywords:

 Respiratory virus infection autologous haematopoietic stem cell transplantation nosocomial infection

BORIS DOI:

 10.48350/151868

URI:

 https://boris.unibe.ch/id/eprint/151868

Actions (login required)

Edit item Edit item
Provide Feedback